News and Events

Larry Gerrans comments on CFO.com

"As the CEO of a life sciences company that has raised more than $6 million from individual investors, we are particularly enthusiastic about the prospects crowdfunding brings to our industry. The risk of fraud has been ever present since the Roman’s coined the phrase, ‘Caveat Emptor’ (Buyer Beware!). The focus should be to accentuate the US greatest common denominator, the goodness of our people. For the US to remain at the leading edge of both innovation and prosperity Americans have to take control of our individual and collective destiny.

We have to face facts; Social Media has changed the world stage. From a finance perspective, US companies are getting crushed by the sophistication and speed with which foreign enterprises and entrepreneurs are amassing funds to accelerate their ventures. We are getting bested by those using the very technologies we created! Moreover, this legislation presents an opportunity to regain the trust and camaraderie among citizens and corporations in restoring those capitalist ideals.

With social media as the driver, communities and industries can invest in their collective interest. The life science community is especially well suited to answer this call. Those endeavored in emerging life sciences are, on the whole, inherently well- educated, well-intentioned, highly professional and highly credible. These trust factors align emerging life science companies with the inspiration of an investing public.

Nothing is more meaningful to an investor or the founder of a Life Science company than the opportunity to 'Do Well by Doing Good'. Sentimentally, Crowdfunding presents the entrepreneur with an incredibly meaningful socioeconomic mandate. It is one thing to grow shareholder value on behalf of some perceivably ruthless institutional investor. It is an especially meaningful mandate to be entrusted to steward the hard- earned dollars of a cancer victim."

Original article:

http://www3.cfo.com/article/2012/4/regulation_obama-signs-jobs-act

Larry Gerrans comments on Forbes jobs article

"As an entrepreneur in the life sciences, I’ve also been closely watching the JOBS act. While I wholeheartedly agree that the act will spur entrepreneurship and increase job growth, I also believe this legislation brings a significant opportunity for individual investors. America’s greatest asset has always been its people. The US was built upon microfunding. People doing business with people is the premise that resides at the very core of Capitalist ideals. This legislation beacons a return to civics and to personal enterprise. To remain at the leading edge of both innovation and prosperity Americans have to take control of our individual and collective destiny. This legislation presents an opportunity to regain the trust and camaraderie among citizens and corporations in restoring those capitalist ideals. With social media as the driver, communities and industries can invest in their collective interest."

Original article:

http://www.forbes.com/sites/work-in-progress/2012/04/05/jobs-act-to-jumpstart-the-job-market/

FDA REGULATORY DISCLOSURE: Sanovas Inc. is an emerging technology company.
These products are investigational medical devices that have not been approved or cleared for use in the United States.